Article
- Author:
- Randy Dotinga
Publish date: November 1, 2022
News
- Author:
- Randy Dotinga
Publish date: November 1, 2022
Registry study suggests different effects from local and systemic types of hormone therapy plus age.
News
- Author:
- Randy Dotinga
Publish date: October 31, 2022
Doctors warn that lost abortion rights put many pregnant patients with sickle cell disease (SCD) in danger.
News
- Author:
- Randy Dotinga
Publish date: October 27, 2022
Even before Dobbs, few offered mifepristone/misoprostol to patients with early pregnancy loss, small survey suggests.
News
- Author:
- Randy Dotinga
Publish date: October 27, 2022
They were more likely than counterparts to get pregnant and have live births, new study finds.
Article
- Author:
- Randy Dotinga
Publish date: October 26, 2022
News
- Author:
- Randy Dotinga
Publish date: October 21, 2022
A rare blood cancer remains incurable, yet new therapies have yielded improved prognoses and survival rates.
Article
- Author:
- Randy Dotinga
Publish date: October 19, 2022
Article
- Author:
- Randy Dotinga
Publish date: October 10, 2022
News
- Author:
- Randy Dotinga
Publish date: October 3, 2022
Leukemia & Lymphoma Society project offers free genomic screening, plus access to subtrials.
News
- Author:
- Randy Dotinga
Publish date: September 30, 2022
Study suggests that the venetoclax-gilteritinib drug combination “potentially improves response frequency and depth.”
News
- Author:
- Randy Dotinga
Publish date: September 19, 2022
Sibling cancer doctors turned their Twitter account into an online watering hole for oncologists.
News
- Author:
- Randy Dotinga
Publish date: September 19, 2022
This rare blood disorder is often misdiagnosed, but a pricey new drug offers relief.
News
- Author:
- Randy Dotinga
Publish date: September 19, 2022
If these tests become standard, the oncology field will need to navigate a thicket of new challenges.
Article
- Author:
- Randy Dotinga
Publish date: September 16, 2022
